Correlation Between GainClients and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GainClients and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GainClients and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GainClients and Mydecine Innovations Group, you can compare the effects of market volatilities on GainClients and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GainClients with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of GainClients and Mydecine Innovations.

Diversification Opportunities for GainClients and Mydecine Innovations

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GainClients and Mydecine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GainClients and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and GainClients is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GainClients are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of GainClients i.e., GainClients and Mydecine Innovations go up and down completely randomly.

Pair Corralation between GainClients and Mydecine Innovations

If you would invest  0.70  in Mydecine Innovations Group on October 4, 2024 and sell it today you would lose (0.40) from holding Mydecine Innovations Group or give up 57.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

GainClients  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
GainClients 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GainClients has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, GainClients is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Mydecine Innovations 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

GainClients and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GainClients and Mydecine Innovations

The main advantage of trading using opposite GainClients and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GainClients position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind GainClients and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years